Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria
NCT01650077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134
Last updated 2019-05-14
Summary
Non-interventional study consisting of a population of patients who had received for soft tissue sarcoma by at least 2 courses of Yondelis® at a dose of 1.5 mg / m² / 3 weeks after failure or intolerance to doxorubicin / ifosfamide from 2007 to 2011.
Conditions
- Soft Tissue Sarcoma
Sponsors & Collaborators
-
Centre Oscar Lambret
lead OTHER
Principal Investigators
-
Nicolas PENEL, MD · Oscar Lambret Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-21
- Primary Completion
- 2013-12-31
- Completion
- 2014-10-28
Countries
- France
Study Locations
More Related Trials
-
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas
NCT06476704 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
NCT05135975 ·Status: RECRUITING ·Phase: PHASE2
-
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
NCT00339118 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children
NCT06341998 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis
NCT00864318 ·Status: COMPLETED ·Phase: PHASE2
-
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
NCT00130858 ·Status: COMPLETED ·Phase: PHASE2
-
Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children
NCT07137884 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
NCT03458728 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
NCT00003801 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor
NCT05455918 ·Status: RECRUITING ·Phase: PHASE2
-
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
NCT00106158 ·Status: COMPLETED ·Phase: PHASE1
-
Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
NCT01445080 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
NCT03441360 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas
NCT01216839 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)
NCT04447755 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
NCT05608148 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
NCT05734066 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma
NCT01216826 ·Status: UNKNOWN ·Phase: PHASE2
-
Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma
NCT00978471 ·Status: COMPLETED ·Phase: PHASE2
-
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
NCT02557854 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas
NCT07136571 ·Status: WITHDRAWN ·Phase: NA
-
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
NCT01125800 ·Status: COMPLETED ·Phase: PHASE1/PHASE2